BioGaia ABBGLAF 100 OCF Yield % is 2.84 as of Jun. 28, 2026, which is at its 10-year median of 2.84. GuruFocus rates BGLAF with a GF Score™ of 100/100 and a GF Value™ of $13.05. The stock has 5 warning signs investors should review. Among 1,002 Drug Manufacturers companies, BioGaia AB ranks worse than 53.99% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
BioGaia AB OCF Yield % Related Terms
BioGaia AB OCF Yield % Historical Data
* Premium members only.
The historical data trend for BioGaia AB's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioGaia AB OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's OCF Yield % distribution charts can be found below:
* The bar in red indicates where BioGaia AB's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioGaia AB (BGLAF) has a OCF Yield % of 2.84 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on BioGaia AB and its competitors. This is near median its historical median of 2.84. Over the past decade, BioGaia AB's OCF Yield % has ranged from 1.64 to 4.27. According to the industry distribution chart, BioGaia AB ranks #541 out of 1002 companies in the Drug Manufacturers industry, placing it in the top 54%.
Is BioGaia AB's OCF Yield % too high?
BioGaia AB's current OCF Yield % of 2.84 is near median its 10-year median of 2.84. Over the past 10 years, this metric has ranged from a low of 1.64 to a high of 4.27. The Drug Manufacturers industry median OCF Yield % is 3.61. BioGaia AB's value of 2.84 is 21.3% below this industry median. Based on the distribution chart, BioGaia AB ranks #541 out of 1002 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, BioGaia AB has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does BioGaia AB's OCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BioGaia AB ranks #541 out of 1002 companies for OCF Yield %. This places BioGaia AB in the lower half of its industry. The industry median OCF Yield % is 3.61. BioGaia AB's value of 2.84 is 21.3% below this benchmark. Historically, BioGaia AB's own OCF Yield % has ranged from 1.64 to 4.27 over the past decade. While the company's 10-year median is 2.84 vs. the industry median of 3.61, BioGaia AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,002 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioGaia AB's current OCF Yield % of 2.84 is 21.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on BioGaia AB and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioGaia AB's current OCF Yield % is 2.84, which is near median its own 10-year median of 2.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioGaia AB stock overvalued right now?
BioGaia AB (BGLAF) has a current OCF Yield % of 2.84. The stock's GF Value™ is $13.05, compared to a current price of $12.20 — trading 6.5% below its estimated fair value. The current OCF Yield % is 2.84, which is near median its 10-year median of 2.84 and 21.3% below the Drug Manufacturers industry median of 3.61. BioGaia AB's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For BioGaia AB (BGLAF), the current OCF Yield % is 2.84 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioGaia AB (BGLAF) Overvalued in 2026?
Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued.
The current stock price of $12.20 is trading 6.5% below its estimated GF Value™ of $13.05.
Key valuation signals for BGLAF:
OCF Yield %: 2.84 (near median its 10-year median of 2.84)
GF Value™: $13.05 vs. price of $12.20 (6.5% below fair value)
Industry Position: 21.3% below the Drug Manufacturers median (#541 of 1002)
No single metric tells the full story. See the BGLAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
100GF Score
Get the complete analysis for BGLAF
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGLAF has been successfully added to your 
